Burnout is experienced frequently by residents, especially during COVID-19 pandemic. Impacts of the pandemic on clinical workload and training program of the residents has also resulted in burnout, which may impact their clinical performance and safety. Therefore, this paper aims to assess burnout syndrome among surgical residents in Indonesia during COVID-19 pandemic. A cross-sectional survey was conducted on 120 surgical residents (from orthopedics, general surgery, and urology department) of a tertiary referral teaching hospital in Malang using web-based questionnaire. Personal data form and Maslach Burnout Inventory (MBI) for medical personnel were used. There are 3 subscales of MBI: emotional exhaustion (EE), depersonalization (DP), and personal achievement (PA). Comparative and correlative analysis were performed to analyze the socio-demographic, academic, and work-related factors in relation to the subscales scores of MBI-HSS and the presence of burnout. Burnout were experienced by 56.67% of residents in this study. There were statistically significant association regarding burnout and marital status, residency specialty, year of residency, and working hours upon analysis of mean and classification of subscale scores of MBI with the examined factors. This study showed that burnout is a major issue in surgical residents during COVID-19 pandemic and may be associated with certain socio-demographic, academic, and work-related factors. Further studies to identify factors contributing to burnout in residents during COVID-19 pandemic are needed. It is imperative to formulate resident-centered strategies to prevent and address burnout among residents to ensure their overall well-being during this pandemic.
Introduction. Immunotherapy has been widely used in the treatment of various malignancies with satisfactory results. One of the agents for immunotherapy is an inhibitor of programmed cell death-1 and its ligands (PD-1 and PD-L1). However, attempts at utilizing PD-1/PD-L1 immunotherapy in osteosarcoma have not yielded favorable results. This may be due to differences in PD-L1 regulation and the immune landscape in osteosarcoma, as the mechanism is still poorly understood. Therefore, elucidating PD-L1 regulation in osteosarcoma is paramount in order to improve treatment results using immunotherapy. Methods. This is a cross-sectional study conducted in the Department of Anatomical Pathology of Saiful Anwar Hospital using 33 paraffin blocks of confirmed cases of osteosarcoma. Immunohistochemical staining using PD-L1, STAT3, IL6, and EGFR was performed. Statistical analyses were subsequently performed on the immunoexpression data of these antibodies. Results. PD-L1, STAT3, IL6, and EGFR expressions were found in 6 (18.2%), 6 (18.2%), 28 (84.8%), and 30 (90.9%) cases, respectively. There were significant correlations between PD-L1 and STAT3 (r = 0.620, ), PD-L1 and EGFR (r = 0.449, ), as well as STAT3 and EGFR (r = 0.351, ). Conclusion. The existence of a correlation between PD-L1, STAT3, and EGFR indicates the potential role of STAT3 and EGFR in PD-L1 regulation in osteosarcoma, which may become the basis for targeted therapy.
Background. Lymphomas are malignant lymphocyte neoplasms that globally account for 10% of cancers in individuals aged <20 years. Malignant lymphomas are divided into Hodgkin’s lymphoma (HL) and non‐Hodgkin’s lymphoma (NHL). Despite the availability of many therapeutic modalities for lymphoma, such as Brentuximab vedotin, Nivolumab, and Pembrolizumab, it is still necessary to identify appropriate strategies with minimal side effects. Immunotherapy is a promising approach, exemplified by targeting JAK/STAT3 signaling, which can inhibit tumor growth and enhance antitumor immune responses. Hence, STAT3 (signal transducer and activator of transcription 3) is a promising therapeutic target. PD‐L1 (programmed death-ligand 1), an immune checkpoint molecule, is used as a frontline treatment for various cancers. This study aims to determine STAT3 expression and its correlation with PD‐L1 expression in NHL and HL to serve as a basis for further research on anti‐STAT3 and its combination with other therapy targets. Methods. Samples were obtained from paraffin blocks of patients with confirmed diagnoses of NHL and HL, and then immunohistochemical staining was carried out with PD‐L1 and STAT3 antibodies. The collected data were then analyzed using SPSS. Results. Among the 10 HL patients, no patients (0%) expressed STAT3, while nine patients (90%) expressed PD‐L1. Among the 10 NHL patients, 1 patient (10%) expressed STAT3, while six patients (60%) expressed PD‐L1. There were no significant differences in STAT3 expression and PD‐L1 expression between HL patients and NHL patients. There was no correlation between STAT3 and PD‐L1 expression in HL and NHL because almost all STAT3 expressions were negative. Conclusion. Although this study revealed no differences between STAT3 and PD‐L1 expression in HL and NHL and no significant correlation between STAT3 and PD‐L1 expression in HL and NHL, this may serve as the basis for understanding the role of STAT3 and PD‐L1 in the regulation of HL and NHL, which may be useful for further research targeting STAT3 and PD‐L1 immunotherapy in HL and NHL.
Background: Spindle cell lesions of the breast include both benign and malignant tumors, with metaplastic carcinoma (MBC) and malignant phyllodes tumor (MPT) being the key malignant entities requiring differentiation due to distinct treatment strategies and prognoses. MBCs are rare, aggressive triple-negative breast cancers with significant histological and molecular heterogeneity. They often harbor TP53, PIK3CA, and EGFR mutations and are believed to arise from epithelial precursors. MBCs require wide surgical margins (radical mastectomy), and standard chemotherapy is often ineffective due to tumor heterogeneity. In contrast, MPTs are fibroepithelial tumors with a characteristic leaf-like growth pattern and originate from stromal—epithelial interactions. They are primarily treated with wide surgical excision (simple mastectomy), with limited evidence supporting adjuvant therapy. Malignant progression in MPTs is linked to TP53, MED12, and EGFR mutations, along with chromosomal abnormalities such as 1q gain. Differentiating MBC from MPT is challenging due to overlapping histological and immunohistochemical features. MBCs typically express epithelial markers like cytokeratin and p63, while MPTs show stromal overgrowth with minimal epithelial marker expression. Although advanced imaging techniques like MRI can assist in diagnosis, histopathological and immunohistochemical evaluation remain crucial. This article is a structured narrative literature review, synthesizing current evidence from peer-reviewed studies retrieved through a targeted search of PubMed, Scopus, and Web of Science without year restriction, prioritizing recent publications. The findings are organized into clinical, histopathological, immunohistochemical, and molecular aspects to facilitate accurate differentiation between MBC and MPT. In conclusion, integrating clinicopathological, immunohistochemical, and molecular data is essential for distinguishing these rare tumors, as they differ in pathogenesis, treatment approaches, and prognosis, thereby guiding optimal patient management.
3 October 2026 in Journal of Surgical Case Reports
Valentino’s syndrome (VS) is a rare presentation of perforated peptic ulcer disease causing right lower quadrant (RLQ) pain mimicking acute appendicitis. Secondary appendiceal perforation with fungal colonization is exceptionally uncommon. A 65-year-old woman presented with worsening RLQ pain, nausea, vomiting, diffuse peritoneal irritation, McBurney tenderness, and hemodynamic instability. Contrast-enhanced computed tomography demonstrated pneumoperitoneum, a pre-pyloric gastric wall defect, and periappendiceal inflammation suggestive of VS. Exploratory laparotomy confirmed generalized peritonitis from pre-pyloric gastric perforation with contamination tracking along the right paracolic gutter. A retrocecal appendix with secondary tip perforation further obscured the diagnosis. Appendectomy and primary gastric repair were performed. Histopathology showed extensive necrosis and fungal hyphae morphologically consistent with Aspergillus spp. on Grocott-Gomori methenamine silver staining, interpreted as secondary fungal involvement. This case broadens the clinical spectrum of VS and highlights careful histopathological interpretation in severely necrotic tissue.
1 January 2022 in Open Access Macedonian Journal of Medical Sciences
Bone neoplasms are rarely found; however, they usually occur in young patients. It is imperative to diagnose these conditions promptly and accurately, as patient’s outcomes also depend on timely and appropriate treatments. Fine Needle Aspiration Biopsy (FNAB) is increasingly utilized as a method of establishing preoperative diagnosis of bone tumors because it is less invasive, rapid, and cost-effective. This study aims to determine the diagnostic value of the presence of certain cytological features in FNAB for bone tumors, evaluate cytological features to differentiate between benign and malignant bone tumors, and determine the cut-off point of the presence of certain cytological features of FNAB in bone tumors. This study is an analytical cross-sectional study to 35 bone tumor cases which underwent FNAB and subsequent histopathological examination from January 2014 – December 2017 in the Department of Anatomic Pathology of Saiful Anwar General Hospital. Diagnostic value testing was performed using 2x2 table and Receiver Operating Characteristic (ROC) curve to determine the sensitivity, specificity, and accuracy of FNAB by evaluating cytological features of anaplasia in differentiating between benign and malignant bone tumors in comparation to histopathological examination. The result revealed that the presence of >4 cytological features of anaplasia without the presence of clinicoradiological data yield 81.82% sensitivity, 100% specificity, 100% positive predictive value, 76.47% negative predictive value, and 88.57% accuracy. In conclusion, cytological features of anaplasia could become a reliable predictor in determining benignity and malignancy of bone tumors especially in cases where clinicoradiological data are insufficient.